Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters

Publication year range
1.
Immunopharmacol Immunotoxicol ; 43(6): 806-812, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34694960

ABSTRACT

PURPOSE: Using antibodies to block the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway as an immunotherapy has achieved great success in the clinical treatment of various types of carcinoma. However, the efficacy is limited because of tumor-mediated immune immunosuppression and evasion. This study demonstrated that inhibiting the PI3K pathway with (-)-4-O-(4-O-ß-D-glucopyranosylcaffeoyl) quinic acid (QA), a new compound from endophytic fungus Penicillium citrinum of Avicennia marina, enhanced the therapeutic efficacy of anti-PD-L1 antibody against esophageal tumors. MATERIALS AND METHODS: mEC25 cells were injected into C57BL/6 mice to establish a syngeneic esophageal tumor model. Tumor infiltration lymphocytes (TILs) were analyzed by flow cytometry. Gene and protein expression was detected by qPCR and western blot, respectively. Moreover, the therapeutic effects of QA combining with anti-PD-L1 antibody were evaluated in the tumor model. RESULTS: These data demonstrated that inhibition of PI3K with QA could overcome immunosuppression and promote the response of T-lymphocytes, resulting in the restoration of cytotoxic T cell-mediated tumor control. QA and anti-PD-L1 combination therapy significantly delayed tumor growth. CONCLUSIONS: Our results provide a scientific basis to develop combination therapies involving anti-PD-L1 and PI3K inhibitors to improve responses in patients with esophageal cancer.


Subject(s)
B7-H1 Antigen/antagonists & inhibitors , Esophageal Neoplasms/drug therapy , Immune Checkpoint Inhibitors/administration & dosage , Phosphoinositide-3 Kinase Inhibitors/administration & dosage , Quinic Acid/administration & dosage , Signal Transduction/drug effects , Animals , B7-H1 Antigen/metabolism , Cell Line, Tumor , Drug Therapy, Combination , Esophageal Neoplasms/metabolism , Male , Mice , Mice, Inbred C57BL , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction/physiology , Treatment Outcome , Tumor Microenvironment/drug effects , Tumor Microenvironment/physiology , Xenograft Model Antitumor Assays/methods
2.
Pharm Biol ; 58(1): 999-1005, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32981407

ABSTRACT

CONTEXT: 5-Caffeoylquinic acid (5-CQA) is one of the most abundant compounds found in natural foods including coffee. OBJECTIVE: We investigated whether 5-CQA had a cytoprotective effect through the NF-E2-related factor 2 (Nrf2)-antioxidant response element (ARE) signalling pathway. MATERIALS AND METHODS: Nrf2 activation in response to 5-CQA treatment at the concentration of 10-100 µM is evaluated by Western blotting of Nrf2 and ARE reporter gene assay as well as its target gene expression in HepG2 cells. Intracellular reactive oxygen species (ROS) and glutathione (GSH) levels were measured in the tert-butyl hydroperoxide-induced hepatocytes to examined cytoprotective effect of 5-CQA (10-100 µM). The specific role of 5-CQA on Nrf2 activation was examined using Nrf2 knockout cells or Nrf2 specific inhibitor, ML-385. RESULTS: Nuclear translocation of Nrf2 is increased by 5-CQA in HepG2 cells which peaked at 6 h. Consequently, 5-CQA significantly increases the ARE reporter gene activity and downstream antioxidant proteins, including glutamate cysteine ligase (GCL), hemeoxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1, and Sestrin2. Nrf2 deficiency or inhibition completely antagonized ability of 5-CQA to induce HO-1 and GCL expression. Cells pre-treated with 5-CQA were rescued from tert-butyl hydroperoxide-induced ROS production and GSH depletion. Nrf2 activation by 5-CQA was due to increased phosphorylation of MAPKs, AMPK and PKCδ. DISCUSSION AND CONCLUSIONS: Taken together, our results demonstrate that as a novel Nrf2 activator, 5-CQA, may be a promising candidate against oxidative stress-mediated liver injury. Additional efforts are needed to assess 5-CQA, as a potential therapeutic in liver diseases in vivo and in humans.


Subject(s)
Cell Death/drug effects , Hepatocytes/drug effects , Oxidative Stress/drug effects , Quinic Acid/analogs & derivatives , Antioxidant Response Elements/drug effects , Antioxidants/metabolism , Dose-Response Relationship, Drug , Gene Knockout Techniques , Glutathione/metabolism , Hep G2 Cells , Hepatocytes/metabolism , Humans , NF-E2-Related Factor 2/metabolism , Protective Agents/administration & dosage , Protective Agents/pharmacology , Quinic Acid/administration & dosage , Quinic Acid/pharmacology , Reactive Oxygen Species/metabolism
3.
Eur J Nutr ; 56(8): 2541-2556, 2017 Dec.
Article in English | MEDLINE | ID: mdl-27535559

ABSTRACT

PURPOSE: Yerba maté is widely consumed in South America as different beverages, such as maté tea (roasted leaves) and chimarrão (green dried leaves), and linked to health benefits, mainly attributed to chlorogenic acids (CGAs). Health effects of CGAs depend on their bioavailability, but such data are scarce. The aim of this study was to investigate the distribution of CGAs and metabolites in tissues, hepatic and plasmatic kinetic profile and urinary excretion after ingestion of maté tea or 5-caffeoylquinic acid (5-CQA). METHODS: Wistar rats ingested maté tea (MT) or 5-CQA (ST) and were killed after 1.5 h for tissue distribution analysis (pilot study) or at 0.5, 1, 2, 4 and 8 h for liver and plasma kinetics (main experiment). Urine was collected in metabolic cages. Biological samples were analyzed by UPLC-DAD-MS with and without incubation with ß-glucuronidase and sulfatase. RESULTS: CGAs and metabolites were detected in all tissues. Caffeic acid was the main compound in plasma up to 2 h after ingestion of maté tea, while 5-CQA predominated in ST group. Concentration of microbial metabolites increased 4 h after gavage and reached higher amounts in MT plasma and liver, when compared to ST group. Approximately 4.0 % of compounds ingested by MT and 3.3 % by ST were recovered in urine up to 8 h after the gavage. CONCLUSION: The study confirms that not only absorption, but also metabolization of CGAs begins in stomach. There were differences in compounds formed from maté tea or isolated 5-CQA, showing that CGAs profile in food may influence qualitatively and quantitatively the metabolites formed in the body.


Subject(s)
Chlorogenic Acid/pharmacokinetics , Ilex paraguariensis/chemistry , Quinic Acid/analogs & derivatives , Teas, Herbal , Animals , Biological Availability , Caffeic Acids/blood , Chlorogenic Acid/administration & dosage , Plant Extracts/administration & dosage , Plant Extracts/pharmacokinetics , Plant Leaves/chemistry , Polyphenols/administration & dosage , Polyphenols/pharmacokinetics , Polyphenols/urine , Quinic Acid/administration & dosage , Quinic Acid/pharmacokinetics , Rats , Rats, Wistar , South America
4.
BMC Complement Altern Med ; 17(1): 320, 2017 Jun 17.
Article in English | MEDLINE | ID: mdl-28623927

ABSTRACT

BACKGROUND: The Gnaphalium pensylvanicum willd. is used in China as a folk medicine to treat anti-inflammatory, cough and rheumatism arthritis. The aim of this study was to evaluate the potential of the extract of G. pensylvanicum to treat hyperuricemia and acute gouty arthritis in animal model. METHODS: G. pensylvanicum extract was evaluated in an experimental model with potassium oxonate (PO) induced hyperuricemia in mice which was used to evaluate anti-hyperuricemia activity and xanthine oxidase (XO) inhibition. Therapies for acute gouty arthritis was also investigated on monosodium urate (MSU) crystal induced paw edema model. RESULTS: G. pensylvanicum extract showed activity in reducing serum uric acid (Sur) through effect renal glucose transporter 9 (GLUT9), organic anion transporter 1 (OAT1) and urate transporter 1 (URAT1) mainly and inhibited XO activity in vivo of mice with PO induced hyperuricemia. The extract of G. pensylvanicum also showed significant anti-inflammatory activity and reduced the paw swelling on MSU crystal-induced paw edema model. Meanwhile, 13 caffeoylquinic acid derivatives and 1 flavone were identified by UPLC-ESI-MS/MS as the main active component of G. pensylvanicum. CONCLUSIONS: The extract of G. pensylvanicum showed significant effect on evaluated models and therefore may be active agents for the treatment of hyperuricemia and acute gouty arthritis.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Arthritis, Gouty/drug therapy , Gnaphalium/chemistry , Gout Suppressants/administration & dosage , Hyperuricemia/drug therapy , Plant Extracts/administration & dosage , Quinic Acid/analogs & derivatives , Animals , Anti-Inflammatory Agents/chemistry , Arthritis, Gouty/immunology , Disease Models, Animal , Glucose Transport Proteins, Facilitative/genetics , Glucose Transport Proteins, Facilitative/metabolism , Gout Suppressants/chemistry , Humans , Hyperuricemia/genetics , Hyperuricemia/immunology , Kidney/drug effects , Kidney/metabolism , Male , Mice , Phytotherapy , Plant Extracts/chemistry , Quinic Acid/administration & dosage , Quinic Acid/chemistry , Uric Acid/metabolism
5.
Molecules ; 22(3)2017 Feb 26.
Article in English | MEDLINE | ID: mdl-28245635

ABSTRACT

Chlorogenic acid (5-O-caffeoylquinic acid) is a phenolic compound from thehydroxycinnamic acid family. This polyphenol possesses many health-promoting properties, mostof them related to the treatment of metabolic syndrome, including anti-oxidant, anti-inflammatory,antilipidemic, antidiabetic, and antihypertensive activities. The first part of this review will discussthe role of chlorogenic acid as a nutraceutical for the prevention and treatment of metabolicsyndrome and associated disorders, including in vivo studies, clinical trials, and mechanisms ofaction. The second part of the review will be dealing with the role of chlorogenic acid as a foodadditive. Chlorogenic acid has shown antimicrobial activity against a wide range of organisms,including bacteria, yeasts, molds, viruses, and amoebas. These antimicrobial properties can beuseful for the food industry in its constant search for new and natural molecules for thepreservation of food products. In addition, chlorogenic acid has antioxidant activity, particularlyagainst lipid oxidation; protective properties against degradation of other bioactive compoundspresent in food, and prebiotic activity. The combination of these properties makes chlorogenic acidan excellent candidate for the formulation of dietary supplements and functional foods.


Subject(s)
Chlorogenic Acid/analogs & derivatives , Chlorogenic Acid/administration & dosage , Food Additives/administration & dosage , Metabolic Syndrome/diet therapy , Quinic Acid/analogs & derivatives , Animals , Chlorogenic Acid/therapeutic use , Clinical Trials as Topic , Dietary Supplements , Disease Models, Animal , Food Additives/therapeutic use , Humans , Metabolic Syndrome/prevention & control , Quinic Acid/administration & dosage , Quinic Acid/therapeutic use , Treatment Outcome
6.
IUBMB Life ; 68(2): 156-66, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26748578

ABSTRACT

In our study buffalo kidney cystatin (BKC) is transformed from native conformation to amyloid fibrils when incubated with 20 mM glyoxal for a prolonged time period. These amyloid fibrils are at the heart of a number of pathological disorders. In the presence of 10 mM glyoxal, BKC retained native-like secondary structure, decreased intrinsic and increased ANS fluorescence was observed, characteristics of molten globule state (MG), thus suggesting the occurrence of MG state at this concentration. At 20 mM glyoxal, BKC aggregates were characterized by a further decrease in ANS fluorescence attributable to internalization of hydrophobic clusters owing to protein-protein interaction. Circular dichroism and FTIR spectroscopy further revealed the existence of ß sheet structure and there was an increase in Thioflavin T fluorescence, Rayleigh light scattering, turbidity as well as red shift in congo red absorbance thus confirming the existence of aggregates. We have also studied the anti-aggregation effect of polyol, quinic acid making use of various above mentioned biophysical assays. Our proposed work strongly favors the formation of BKC aggregates in the presence of glyoxal, which is present in higher amounts in pathological conditions owing to defective glycolysis pathway and also use of polyol as an antifibrillating agent.


Subject(s)
Amyloid/metabolism , Glyoxal/metabolism , Kidney/metabolism , Protein Aggregation, Pathological/drug therapy , Quinic Acid/administration & dosage , Amyloid/drug effects , Animals , Buffaloes , Circular Dichroism , Cystatins/metabolism , Kidney/drug effects , Kidney/pathology , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathology , Protein Structure, Secondary/drug effects , Spectroscopy, Fourier Transform Infrared
7.
Pharm Biol ; 54(12): 2864-2870, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27249953

ABSTRACT

CONTEXT: Solidago virgaurea L. (Asteraceae) is traditionally used as an anti-inflammatory for the treatment of various symptoms including cystitis. However, little is known concerning the constituents responsible for this activity and the mechanism of their action. OBJECTIVE: To assess the anti-inflammatory activity of the phenolic-rich fraction of S. virgaurea aerial parts in rats, isolate and assess the activity of the major compounds present. MATERIALS AND METHODS: An HPLC method was developed for the analysis of the phenolic-rich fraction (EtFr). The in vivo anti-inflammatory activity of the EtFr and four isolated compounds (at 25 and 50 mg/kg) were assessed in adult male rats using the carrageenan-induced rat paw oedema model. The levels of the pro-inflammatory cytokines (TNF-α and IL-1ß) were measured using ELISA. RESULTS: 3,5-O-Dicaffeoylquinic acid (1), 3,4-O-dicaffeoylquinic acid (2), 3,4,5-O-tricaffeoylquinic acid (3) and 4,5-O-dicaffeoylquinic acid (4) were isolated from EtFr. Compound 3 (50 mg/kg) showed a highly significant activity in inhibiting the oedema volume after 3 h (88% of the activity of indomethacin at 10 mg/kg). The EtFr and the isolated compounds largely inhibited the excessive production of the inflammatory mediators TNF-α and IL-1ß. DISCUSSION AND CONCLUSION: This is the first report of 3,4,5-tri-O-caffeoylquinic acid (3) in Solidago species. The tricaffeoylquinic acid (3) showed a significantly higher activity than the other three dicaffeoylquinic acids (1, 2, 4) and indomethacin in reduction of TNF-α and IL-1ß concentrations (8.44 ± 0.62 and 5.83 ± 0.57 pg/mL compared to 12.60 ± 1.30 and 52.91 ± 5.20 pg/mL induced by indomethacin, respectively).


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Inflammation Mediators/antagonists & inhibitors , Plant Extracts/administration & dosage , Quinic Acid/analogs & derivatives , Solidago , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Dose-Response Relationship, Drug , Edema/drug therapy , Edema/metabolism , Inflammation Mediators/metabolism , Male , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Quinic Acid/administration & dosage , Quinic Acid/chemistry , Quinic Acid/isolation & purification , Quinic Acid/pharmacology , Random Allocation , Rats , Rats, Sprague-Dawley
8.
Eur J Nutr ; 54(1): 149-56, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24740588

ABSTRACT

PURPOSE: Coffee consumption has been reported to decrease oxidative damage in peripheral white blood cells (WBC). However, effects on the level of spontaneous DNA strand breaks, a well established marker of health risk, have not been specifically reported yet. We analyzed the impact of consuming a dark roast coffee blend on the level of spontaneous DNA strand breaks. METHODS: Healthy men (n = 84) were randomized to consume daily for 4 weeks either 750 ml of fresh coffee brew or 750 ml of water, subsequent to a run in washout phase of 4 weeks. The study coffee was a blend providing high amounts of both caffeoylquinic acids (10.18 ± 0.33 mg/g) and the roast product N-methylpyridinium (1.10 ± 0.05 mg/g). Before and after the coffee/water consumption phase, spontaneous strand breaks were determined by comet assay. RESULTS: At baseline, both groups exhibited a similar level of spontaneous DNA strand breaks. In the intervention phase, spontaneous DNA strand breaks slightly increased in the control (water only) group whereas they significantly decreased in the coffee group, leading to a 27% difference within both arms (p = 0.0002). Food frequency questionnaires indicated no differences in the overall diet between groups, and mean body weight during the intervention phases remained stable. The consumption of the study coffee substantially lowered the level of spontaneous DNA strand breaks in WBC. CONCLUSION: We conclude that regular coffee consumption contributes to DNA integrity.


Subject(s)
Antioxidants/administration & dosage , Coffee , DNA Breaks , Food Handling , Leukocytes/metabolism , Adult , Alkaloids/administration & dosage , Alkaloids/analysis , Alkaloids/urine , Antioxidants/analysis , Biomarkers/blood , Caffeine/administration & dosage , Caffeine/analysis , Coffea/chemistry , Coffee/chemistry , Cohort Studies , Comet Assay , Germany , Hot Temperature , Humans , Male , Patient Compliance , Pyridinium Compounds/administration & dosage , Pyridinium Compounds/analysis , Pyridinium Compounds/urine , Quinic Acid/administration & dosage , Quinic Acid/analogs & derivatives , Quinic Acid/analysis , Seeds/chemistry
9.
Eur J Nutr ; 54(5): 845-54, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25204719

ABSTRACT

PURPOSE: The hypothesis was tested that coffee types differing in content of major constituents also differ with regard to cardiometabolic effects. METHODS: Overweight persons (n = 118) were randomized to consume a dark roast [rich in N-methylpyridinium (NMP)] or medium roast (rich in caffeoylquinic acids, trigonelline) coffee blend for 3 months, after a washout period of 4 weeks. Before and after the intervention period, body weight and 15 further general and biochemical parameters were determined. RESULTS: Participants consumed an average of 4-5 cups per day. Mean body weight, body mass index and waist circumference did not change during the coffee consumption phase in either of the study groups. Systolic blood pressure decreased in the dark roast coffee group only (p < 0.05). High-density lipoprotein cholesterol levels increased in the medium roast coffee group only, and triglyceride levels increased in the dark roast coffee group only. Glucoregulation and insulin levels were not affected, although there was a small increase of hemoglobin A1c values in both groups. An increase of adiponectin levels occurred in the medium roast coffee group only and was negatively associated with NMP concentrations. Differences did not remain statistically significant after correction for multiple testing. CONCLUSIONS: Medium and dark roast coffee blends exert small but possibly relevant different cardiometabolic effects. Further studies of health outcomes in relation to coffee constituents seem warranted.


Subject(s)
Cardiovascular System/drug effects , Coffee/chemistry , Overweight/metabolism , Adiponectin/blood , Adolescent , Adult , Aged , Alkaloids/administration & dosage , Blood Glucose/metabolism , Blood Pressure/drug effects , Body Mass Index , Body Weight , C-Reactive Protein , Cardiovascular System/metabolism , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Fasting , Female , Glycated Hemoglobin/metabolism , Humans , Insulin/blood , Linear Models , Male , Middle Aged , Osteopontin/blood , Prospective Studies , Pyridinium Compounds/administration & dosage , Pyridinium Compounds/blood , Quinic Acid/administration & dosage , Quinic Acid/analogs & derivatives , Waist Circumference , Weight Loss/drug effects , Young Adult
10.
J Sci Food Agric ; 95(9): 1903-10, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25186103

ABSTRACT

BACKGROUND: Chlorogenic acids (CGAs) are widely distributed in plant material, including foods and beverages. 5-Caffeoylquinic acid (5-CQA) is the most studied CGA, but the mechanism of its hypolipidaemic effect remains unclear. This study aimed to determine the effect of 5-CQA on lipid metabolism in the liver of Sprague-Dawley rats fed a high-fat diet (HFD). RESULTS: 5-CQA suppressed HFD-induced increases in body weight and visceral fat-pad weight, serum lipid levels, and serum and hepatic free fatty acids in a dose-dependent manner. Real-time polymerase chain reaction revealed that 5-CQA altered the mRNA expression of the transcription factors peroxisome proliferator-activated receptor α (PPARα) and liver X receptor α (LXRα) and target genes involved in hepatic fatty acid uptake, ß-oxidation, fatty acid synthesis, and cholesterol synthesis. Moreover, hepatic tissue sections from HFD-fed rats showed many empty vacuoles, suggesting that liver cells were filled with more fat droplets. However, 5-CQA significantly ameliorated this effect. CONCLUSION: 5-CQA may improve lipid metabolism disorders by altering the expression of PPARα and LXRα, which are involved in multiple intracellular signalling pathways.


Subject(s)
Anti-Obesity Agents/therapeutic use , Chlorogenic Acid/analogs & derivatives , Dietary Supplements , Liver/metabolism , Obesity/prevention & control , Orphan Nuclear Receptors/antagonists & inhibitors , PPAR alpha/agonists , Quinic Acid/analogs & derivatives , Adiposity , Animals , Anti-Obesity Agents/administration & dosage , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Chlorogenic Acid/administration & dosage , Chlorogenic Acid/therapeutic use , Diet, High-Fat/adverse effects , Fatty Acids, Nonesterified/blood , Fatty Acids, Nonesterified/metabolism , Gene Expression Regulation , Hyperlipidemias/etiology , Hyperlipidemias/metabolism , Hyperlipidemias/pathology , Hyperlipidemias/prevention & control , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/therapeutic use , Lipid Metabolism , Lipids/blood , Liver/pathology , Liver X Receptors , Male , Obesity/etiology , Obesity/metabolism , Obesity/pathology , Orphan Nuclear Receptors/genetics , Orphan Nuclear Receptors/metabolism , PPAR alpha/genetics , PPAR alpha/metabolism , Quinic Acid/administration & dosage , Quinic Acid/therapeutic use , Random Allocation , Rats, Sprague-Dawley
11.
Eur J Nutr ; 53(1): 159-66, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23503803

ABSTRACT

BACKGROUND: Polyphenols are thought to play important roles in human nutrition and health but these health effects are dependent on their bioavailability. This study is one of a series with the aim of determining possible effects of food matrices on caffeoylquinic acid (CQA) bioavailability using ileostomy volunteers. METHODS: After a CQA-free diet, ileostomists consumed coffee (746 µmol total CQA), and CQAs in excreted ileal fluid were subsequently identified and quantified with HPLC-diode array detection and HPLC-ESI-MS/MS. In our previous studies, other food sources such as cloudy apple juice (CAJ) (358 µmol CQA) and apple smoothie (AS) (335 µmol CQA) were investigated with the same model. RESULTS: Interesterification of CQA from both apple matrices was observed during gastrointestinal passage, whereas CQA consumed in coffee was not influenced by interesterification reactions. In total, 74.3, 22.4, and 23.8 % of the CQA from CAJ, AS, and coffee, respectively, were absorbed or degraded. CONCLUSION: Our results show that variations in food matrices and variations in phenolic composition have a major influence on intestinal bioavailability and interesterification of the investigated subclass of polyphenols, the CQAs.


Subject(s)
Ileostomy , Intestinal Absorption , Quinic Acid/analogs & derivatives , Adult , Beverages , Biological Availability , Body Mass Index , Body Weight , Chromatography, High Pressure Liquid , Coffee/chemistry , Female , Healthy Volunteers , Humans , Intestinal Mucosa/metabolism , Malus/chemistry , Polyphenols/chemistry , Quinic Acid/administration & dosage , Quinic Acid/pharmacokinetics
12.
Biomed Chromatogr ; 28(5): 601-9, 2014 May.
Article in English | MEDLINE | ID: mdl-24185835

ABSTRACT

Qingkailing (QKL) injection, a modified modern Chinese medicine preparation, is widely used in the clinic for its significant antipyretic and anti-inflammatory effects, but its serious adverse drug reactions have attracted more and more attention. Series of caffeoylquinic acids in QKL are widely suspected to be the allergens responsible for these adverse drug reactions. Therefore, pharmacokinetic studies of the caffeoylquinic acids are needed. In this paper, a simple, rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry method was developed for the simultaneous determination of chlorogenic acid, neochlorogenic acid, baicalin, geniposide, cholic acid and hyodeoxycholic acid in rat plasma. Chromatographic separation was achieved on a BEH C18 column by a gradient elution at a flow rate of 0.40 mL/min in only 6.0 min. All analytes were monitored by multiple reaction monitoring mode with negative electrospray ionization. The calibration curves of these analytes were all linear (r > 0.9978) over wide concentration ranges. The intra- and inter- day precisions (relative standard deviations) were within 14.3% and accuracy (relative error) ranged from -6.8 to 4.8%. The mean recoveries ranged from 74.5 to 105.6%. This validated method was successfully applied to the pharmacokinetic study of the six analytes in rats following an intravenous administration of QKL injection.


Subject(s)
Chromatography, High Pressure Liquid/methods , Drugs, Chinese Herbal/pharmacokinetics , Quinic Acid/analogs & derivatives , Tandem Mass Spectrometry/methods , Administration, Intravenous , Animals , Drugs, Chinese Herbal/administration & dosage , Male , Quinic Acid/administration & dosage , Quinic Acid/pharmacokinetics , Rats , Rats, Sprague-Dawley , Sensitivity and Specificity
14.
Drug Dev Res ; 75(1): 29-36, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24648047

ABSTRACT

Acute radiation syndrome is induced when a significant portion of the body receives high-dose, as well as high-dose rate, radiation. We have previously identified a quinic acid-based derivative, KZ-41, that protects from radiation injury. Further preclinical efficacy studies were conducted to determine the radiomitigating activity of KZ-41. C57BL/6 mice received total body irradiation (TBI-LD80/30, ¹³7Cs; ∼2 min) followed by either normal saline or KZ-41 (100 mg/kg sc ∼26 h post-TBI). KZ-41 increased 30-day survival by approximately 45% compared with vehicle controls (P < 0.05). To further investigate the potential radiomodulating mechanisms of KZ-41, we developed a combined radiation and vascular injury model. C57BL/6 mice surgically fixed with dorsal windows for dermal vasculature imaging received either sham or TBI (¹³7Cs; 6 Gray). Postcapillary venule injury was induced (24, 48, 72, and 96 h post-TBI) followed by imaging at 5 min and 24 h to assess clot formation and blood flow. Impairment in flow (P < 0.05) and clot formation (P < 0.05) were observed as early as 48 and 72 h, respectively. Thus, vascular injury 72 h post-TBI was used to evaluate intervention (KZ-41; 100 mg/kg i.p. at 12, 36, and 60 h post-TBI) on radiation-induced changes in both flow and clot formation. KZ-41, although not improving flow, increased clot formation (P < 0.05). Platelet counts were lower in both irradiated groups compared with sham controls (P < 0.05). In summary, KZ-41 exerts radiomitigating activity in lethally irradiated mice. Imaging results suggest KZ-41 exerts radiomitigating activity through mechanisms involving promotion of initial clot formation and vascular flow restoration. The imaging model described herein is useful for further examination of radiation-induced vascular injury repair mechanisms.


Subject(s)
Quinic Acid/analogs & derivatives , Radiation-Protective Agents/administration & dosage , Vascular System Injuries/pathology , Venules/drug effects , Venules/injuries , Animals , Blood Cells/drug effects , Disease Models, Animal , Drug Evaluation, Preclinical , Female , Mice , Mice, Inbred C57BL , Quinic Acid/administration & dosage , Radiation Injuries, Experimental/drug therapy , Radiation Injuries, Experimental/pathology , Tumor Necrosis Factor-alpha/metabolism , Vascular System Injuries/drug therapy
15.
Drug Deliv ; 31(1): 2372285, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38952133

ABSTRACT

In this study, chitosan low molecular weight (LCH) and chitosan medium molecular weight (MCH) were employed to encapsulate a yarrow extract rich in chlorogenic acid and dicaffeoylquinic acids (DCQAs) that showed antiproliferative activity against colon adenocarcinoma cells. The design of CH micro/nanoparticles to increase the extract colon delivery was carried out by using two different techniques: ionic gelation and spray drying. Ionic gelation nanoparticles obtained were smaller and presented higher yields values than spray-drying microparticles, but spray-drying microparticles showed the best performance in terms of encapsulation efficiency (EE) (> 94%), also allowing the inclusion of a higher quantity of extract. Spray-drying microparticles designed using LCH with an LCH:extract ratio of 6:1 (1.25 mg/mL) showed a mean diameter of 1.31 ± 0.21 µm and EE values > 93%, for all phenolic compounds studied. The release profile of phenolic compounds included in this formulation, at gastrointestinal pHs (2 and 7.4), showed for most of them a small initial release, followed by an increase at 1 h, with a constant release up to 3 h. Chlorogenic acid presented the higher release values at 3 h (56.91% at pH 2; 44.45% at pH 7.4). DCQAs release at 3 h ranged between 9.01- 40.73%, being higher for 1,5- and 3,4-DCQAs. After gastrointestinal digestion, 67.65% of chlorogenic and most DCQAs remained encapsulated. Therefore, spray-drying microparticles can be proposed as a promising vehicle to increase the colon delivery of yarrow phenolics compounds (mainly chlorogenic acid and DCQAs) previously described as potential agents against colorectal cancer.


Subject(s)
Achillea , Cell Proliferation , Chitosan , Chlorogenic Acid , Colorectal Neoplasms , Nanoparticles , Particle Size , Plant Extracts , Chitosan/chemistry , Humans , Plant Extracts/pharmacology , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Achillea/chemistry , Chlorogenic Acid/pharmacology , Chlorogenic Acid/administration & dosage , Chlorogenic Acid/chemistry , Nanoparticles/chemistry , Cell Proliferation/drug effects , Colorectal Neoplasms/drug therapy , Cell Line, Tumor , Quinic Acid/analogs & derivatives , Quinic Acid/pharmacology , Quinic Acid/chemistry , Quinic Acid/administration & dosage , Drug Liberation , Drug Delivery Systems/methods , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/chemistry , Colon/drug effects , Colon/metabolism , Drug Carriers/chemistry , Molecular Weight
16.
Phytother Res ; 25(6): 851-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21104945

ABSTRACT

Hippuric acid is synthesized and produced primarily by the gastrointestinal (GI) microflora. However, there is no known health benefit for hippuric acid except its catabolic conjugation of benzene-type compounds via glycine and subsequent excretion in the urine. For years the GI tract microflora were known to metabolize quinic acid to hippuric acid. Recently it was also proposed that DNA repair was strongly enhanced by quinic acid. In order to explain these quinic acid effects, Pero and colleagues have examined whether tryptophan and nicotinamide were also enhanced by quinic acid levels in urine. They were indeed, and so another study was designed using a natural supplement source of quinic acid called AIO + AC-11®, and then the effects of intervention were measured after only 21 days. It was possible to show profound increases in quinic acid that were again paralleled by increases in tryptophan and nicotinamide urinary levels. Because the high pressure liquid chromatography (HPLC) methods differed greatly between the two studies, differences in chemical analyses probably did not contribute to the data base.


Subject(s)
Niacinamide/urine , Quinic Acid/administration & dosage , Quinic Acid/urine , Tryptophan/urine , Adolescent , Adult , Aged , Antioxidants/administration & dosage , Antioxidants/pharmacokinetics , Dietary Supplements , Female , Hippurates/metabolism , Humans , Life Style , Male , Middle Aged , Niacinamide/biosynthesis , Plant Extracts/administration & dosage , Plant Extracts/pharmacokinetics , Quinic Acid/pharmacokinetics , Tryptophan/biosynthesis , Young Adult
17.
J Acad Nutr Diet ; 120(6): 1002-1015.e5, 2020 06.
Article in English | MEDLINE | ID: mdl-31982373

ABSTRACT

BACKGROUND: Biological and epidemiological evidence supports an inverse association of phenolic acids with obesity-related chronic diseases. However, no previous study has prospectively evaluated the relationship between subclasses and individual compounds of phenolic acids and the risk of postmenopausal breast cancer, one of the most important and prevalent obesity-related cancer sites. OBJECTIVE: This study examined associations between subclasses of phenolic acids, including hydroxycinnamic and hydroxybenzoic acids intake, and risk of breast cancer. DESIGN: The Seguimiento Universidad de Navarra (SUN) Project is a dynamic, permanently open prospective cohort which started in 1999. PARTICIPANTS/SETTING: Participants were 10,812 middle-aged women. All of them were university graduates. MAIN OUTCOME MEASURES: Usual diet was assessed at baseline and after 10 years of follow-up with a 136-item food frequency questionnaire. Phenolic acid intake was calculated by matching food consumption with the Phenol-Explorer database on phenolic acids content of each reported food item. STATISTICAL ANALYSIS PERFORMED: Participants were classified according to tertiles of subclasses or individual compounds of phenolic acids. Cox regression models were fitted to estimate multivariable-adjusted hazard ratios and 95% CIs for breast cancer incidence. RESULTS: Over an average of 11.8 years of follow-up, 101 incident cases of breast cancer were confirmed. After multivariable adjustment, an inverse association between hydroxycinnamic acids intake and breast cancer was observed (hazard ratio third tertile vs first tertile 0.37, 95% CI 0.16 to 0.85; P for trend=0.029) among postmenopausal women. Specifically, chlorogenic acids (3-, 4-, and 5- caffeoylquinic acids) showed the strongest inverse association (hazard ratio third tertile vs first tertile 0.33, 95% CI 0.14 to 0.78; P for trend=0.012). CONCLUSIONS: A higher intake of hydroxycinnamic acids, especially from chlorogenic acids-present in coffee, fruits, and vegetables-was associated with a lower incidence of breast cancer among postmenopausal women. Future observational studies are needed to corroborate these results.


Subject(s)
Breast Neoplasms/epidemiology , Coumaric Acids/administration & dosage , Diet, Mediterranean , Hydroxybenzoates/administration & dosage , Adult , Chlorogenic Acid/administration & dosage , Coffee , Cohort Studies , Female , Fruit , Humans , Middle Aged , Postmenopause , Prospective Studies , Quinic Acid/administration & dosage , Quinic Acid/analogs & derivatives , Risk Factors , Spain , Vegetables
18.
Nutrients ; 12(2)2020 Feb 14.
Article in English | MEDLINE | ID: mdl-32075202

ABSTRACT

The accumulation of amyloid ß (Aß) in the brain is a major pathological feature of Alzheimer's disease (AD). In our previous study, we demonstrated that coffee polyphenols (CPP) prevent cognitive dysfunction and Aß deposition in the brain of an APP/PS2 transgenic mouse AD model. The underlying mechanisms, however, remain to be elucidated. Here, we investigated the effects of the chronic administration of 5-caffeoylquinic acid (5-CQA), the most abundant component of CPP, on cognitive dysfunction in APP/PS2 mice to identify the role of CPP in Aß elimination. Relative to the untreated controls, the mice fed a 5-CQA-supplemented diet showed significant improvements in their cognitive function assessed by Y-maze and novel object recognition tests. Histochemical analysis revealed that 5-CQA substantially reduced Aß plaque formation and neuronal loss in the hippocampi. Moreover, 5-CQA upregulated the gene encoding low-density lipoprotein receptor-related protein 1, an Aß efflux receptor, and normalized the perivascular localization of aquaporin 4, which facilitates Aß clearance along the paravascular pathway. These results suggest that 5-CQA reduces Aß deposition in the brain by modulating the Aß clearance pathways and ameliorating cognitive decline and neuronal loss in APP/PS2 mice. Thus, 5-CQA may be effective in preventing cognitive dysfunction in AD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/psychology , Amyloid beta-Peptides/metabolism , Brain/metabolism , Coffee , Cognition/drug effects , Cognitive Dysfunction/prevention & control , Phytotherapy , Polyphenols/administration & dosage , Polyphenols/pharmacology , Quinic Acid/analogs & derivatives , Animals , Disease Models, Animal , Female , LDL-Receptor Related Proteins/genetics , LDL-Receptor Related Proteins/metabolism , Male , Mice, Transgenic , Quinic Acid/administration & dosage , Quinic Acid/pharmacology
19.
J Pharm Biomed Anal ; 177: 112809, 2020 Jan 05.
Article in English | MEDLINE | ID: mdl-31541942

ABSTRACT

A simple and specific, rapid resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for determination of chlorogenic acid in human plasma using neochlorogenic acid as the internal standard. Plasma samples were precipitated with methanol and separated on a Zorbax C18 column (50 × 2.1 mm, i.d. 1.8 µm) at a flow rate of 0.4 mL/min using a gradient mobile phase of methanol-water containing 0.1% formic acid (v/v). The detection was performed on a triple quadrupole tandem mass spectrometer by multiple reaction monitoring in negative ESI mode. The method was fully validated over the concentration range of 10-2000 ng/mL. The indicators of inter- and intra-day precision (RSD%) were all within 10.7%, and the accuracy (RE%) was ranged from -3.0% to 10.6%. Moreover, we evaluated this bioanalytical method by re-analysis of incurred samples as an additional measure of assay reproducibility. This method was successfully applied to pharmacokinetic study of CGA in Chinese subjects with advanced solid tumor after intramuscular injection administration of Chlorogenic acid for injection (CAFI).


Subject(s)
Anticarcinogenic Agents/blood , Chlorogenic Acid/analogs & derivatives , High-Throughput Screening Assays/methods , Neoplasms/drug therapy , Quinic Acid/analogs & derivatives , Tandem Mass Spectrometry/methods , Anticarcinogenic Agents/administration & dosage , Anticarcinogenic Agents/pharmacokinetics , Area Under Curve , China , Chlorogenic Acid/administration & dosage , Chlorogenic Acid/blood , Chlorogenic Acid/pharmacokinetics , Chromatography, High Pressure Liquid/methods , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Stability , Humans , Injections, Intramuscular , Neoplasms/blood , Quinic Acid/administration & dosage , Quinic Acid/blood , Quinic Acid/pharmacokinetics , Reproducibility of Results , Sensitivity and Specificity
20.
Arch Med Res ; 51(1): 8-12, 2020 01.
Article in English | MEDLINE | ID: mdl-32086110

ABSTRACT

BACKGROUND: Lung adenocarcinoma (LAC) is a major worldwide cause of death by cancer, it shows high aggressiveness, functional decline, systemic compromise and severe cachexia, which might be counteracted by dietary redox-active phytochemicals. Therefore, our aim was to establish the anticancer effects of the oral intake of quercetin and 5 caffeoylquinic acid. METHODS: LAC-1-bearing male Balb/c mice received quercetin (0-25 µg/kg/d) and 5 caffeoylquinic acid (0-120 µg/kg/d) for three weeks, with different organic and biochemical variables being then compared with ANOVA and the Fisher Test (p <0.05). RESULTS: Quercetin delayed 1.18 fold tumour appearance and increased 8.87 fold non-neoplastic body weight gain, whereas 5 caffeoylquinic acid did it in a lesser extent (1.17 and 2.48 fold, respectively), with tumour weight being consequent with the evolution time. Quercetin induced >1.15 fold tumour hydroperoxides and lipoperoxides, whereas 5 caffeoylquinic acid induced only lipoperoxides. Although both phytochemicals reduced <0.85 fold hydroperoxides and lipoperoxides in the kidney, only quercetin was also antioxidant in the liver. Additionally, 5 caffeoylquinic acid increased >1.15 fold hepatic and renal weights. Although these phytochemicals did not modify telencephalic interleukin 6 production, quercetin augmented 2.51 fold interleukin 6 in the diencephalon, whereas 5 caffeoylquinic acid decreased it 0.43 fold. CONCLUSIONS: Quercetin delayed lung adenocarcinoma appearance and increased the non-neoplastic body weight gain in mice with tumour oxidative stress, without brain interleukin 6 participation. 5 caffeoylquinic acid showed similar effects, although they were weaker. Additionally, quercetin acted as a hepatic and renal antioxidant, whereas 5 caffeoylquinic acid only exerted this effect in the kidney. Therefore, safe oral doses of this flavonoid are promissory to modulate lung cancer progression, with further studies being encouraged.


Subject(s)
Adenocarcinoma of Lung/drug therapy , Lung Neoplasms/drug therapy , Quercetin/administration & dosage , Quinic Acid/analogs & derivatives , Adenocarcinoma of Lung/metabolism , Adenocarcinoma of Lung/pathology , Administration, Oral , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Antioxidants/pharmacology , Body Weight/drug effects , Cachexia/drug therapy , Cachexia/metabolism , Cachexia/pathology , Disease Progression , Interleukin-6/blood , Liver/drug effects , Liver/metabolism , Liver/pathology , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred BALB C , Oxidation-Reduction , Oxidative Stress/drug effects , Quercetin/pharmacology , Quinic Acid/administration & dosage , Quinic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL